Literature DB >> 6773450

Effect of chronic lead exposure on the canine bone marrow.

E S Mitema, F W Oehme, L Penumarthy, W E Moore.   

Abstract

The effect of chronic oral led acetate administration on canine bone marrow was studied. Two dogs (group 1) were used as controls, 4 dogs (group 2) were given 2 mg of lead/kg of body weight daily, and 4 dogs (group 3) were given 5 mg of lead/kg daily. After a 7-day stabilizaion period, lead dosing was conducted for 91 days (13 weeks), after which half of each group was treated with calcium ethylenediaminetetraacetic acid. All dogs were then observed for another 28 days (4 weeks). Blood lead values and bone marrow cellular changes were monitored once a week during the 126 days (18 weeks) of study. Lead-dosed dogs had lower weight gains than the controls. Clinical signs of toxicosis were observed after 6 weeks in one dog in group 3. Anorexia, body weight loss, CNS depression, muscular weakness, and trembling were seen. Blood lead concentrations increased in all group 2 and 3 dogs. Lead caused increases in bone marrow segmented neutrophils and myeloid series cells, and increased myeloid:erythroid ratios. Blood lead concentrations and myeloid:erythroid ratios decreased after cessation of lead administration.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6773450

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  3 in total

1.  Bone marrow cells of mice under the influence of low lead doses.

Authors:  E Schlick; K D Friedberg
Journal:  Arch Toxicol       Date:  1982-03       Impact factor: 5.153

2.  The influence of low lead doses on the reticulo-endothelial system and leucocytes of mice.

Authors:  E Schlick; K D Friedberg
Journal:  Arch Toxicol       Date:  1981-06       Impact factor: 5.153

3.  The imaging quantification of multiple organs by dynamic 18F-FDG PET/CT in discharged COVID-19 patients: A prospective pilot study.

Authors:  Jijin Yao; Jing Liu; Lei Bi; Yiying Huang; Lu Wang; Fanwei Zhang; Ying Wang; Hongjun Jin
Journal:  Int J Med Sci       Date:  2022-09-06       Impact factor: 3.642

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.